Monoamine involvement in the overeating caused by muscimol injection in the rat nucleus raphe dorsalis and the effects of d-fenfluramine and d-amphetamine.
Injections of 5,7-dihydroxytryptamine in the nucleus raphe dorsalis did not significantly modify the eating caused by muscimol (100 ng) injected in the same area of freely fed rats 11 days later. Eating caused by muscimol, like food intake in starved rats, was significantly reduced by phenoxybenzamine (5, 10 and 20 mg/kg i.p.). Penfluridol (2.5 and 5 mg/kg p.o.), a dopamine receptor blocker, markedly reduced muscimol-induced eating, but had no effect on the food intake of starved rats. d-Fenfluramine (2.5 mg/kg i.p.), a releaser of serotonin from nerve terminals, significantly reduced eating in muscimol-injected and starved animals whereas d-amphetamine 1.25 and 2.5 mg/kg i.p. only inhibited the food intake of starved rats. Eating elicited by muscimol injected in the nucleus raphe dorsalis appears to constitute a catecholamine-mediated model of hyperphagia selectively inhibited by agents which increase serotonin transmission.
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology*; D003913:Dextroamphetamine / Q000494:pharmacology*; D005247:Feeding Behavior / Q000187:drug effects / Q000502:physiology*; D005277:Fenfluramine / Q000494:pharmacology*; D005508:Food Deprivation / Q000502:physiology; D007267:Injections; D008297:Male; D009118:Muscimol / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology*; D010395:Penfluridol / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011903:Raphe Nuclei; D051381:Rats
D001679:Biogenic Amines; D010080:Oxazoles; D010643:Phenoxybenzamine; D010395:Penfluridol; D009118:Muscimol; D005277:Fenfluramine; D015116:5,7-Dihydroxytryptamine; D003913:Dextroamphetamine